Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
In radiation therapy, the usual idea of ‘symptoms and causes’ is different. The ’cause’ for using radiation is the medical need to control a cancer in a specific area. The ‘symptoms’ are the side effects patients feel when healthy tissue is affected by radiation. This section explains why radiation is chosen and how side effects happen, showing that radiation is an active treatment with expected effects on the body.
The primary indication (cause) for radiation therapy is the presence of a radiosensitive tumor where local control is paramount for survival or quality of life. This includes the definitive treatment of prostate, head and neck, and cervical cancers, where radiation serves as a curative alternative to organ-sacrificing surgery. It is also utilized as an adjuvant therapy (after surgery) in breast and brain tumors to sterilize the surgical bed of microscopic residual disease, or as a neoadjuvant therapy (before surgery) in rectal and esophageal cancers to downstage the tumor and improve resectability. The decision to treat is driven by the tumor’s radiobiological properties, its anatomical location, and the need to preserve function.
The “symptoms” or acute side effects of radiation therapy are site-specific and generally manifest in tissues with rapid cellular turnover. These effects typically begin two to three weeks into treatment. The pathophysiology involves the depletion of stem cells in the basal layers of the epithelium. As mature cells shed naturally, there are insufficient new cells to replace them due to radiation-induced mitotic arrest.
Late effects occur months or years after treatment and are often permanent. These are driven by damage to the slowly proliferating stromal cells (fibroblasts) and the microvasculature (endothelial cells). Radiation induces chronic oxidative stress and inflammation, leading to overproduction of TGF-beta. This cytokine drives collagen deposition, leading to fibrosis (scarring) and loss of tissue elasticity.
Vascular damage leads to endarteritis obliterans—a thickening of the blood vessel walls that narrows the lumen and reduces blood flow. This chronic ischemia can lead to tissue atrophy, poor wound healing, and, in severe cases, necrosis (such as osteoradionecrosis of the jaw). The “symptoms” of late effects are thus the clinical manifestations of this progressive fibrosis and vascular insufficiency.
Complex signaling pathways mediate the cellular response to radiation. The ATM/ATR kinase pathway acts as the primary sensor of DNA double-strand breaks. Its activation halts the cell cycle to allow for repair. In tumors with mutated p53 (a common occurrence), this checkpoint fails, leading to aberrant mitosis and cell death. However, this same signaling in normal tissues triggers the release of danger signals (DAMPs) that recruit immune cells. While this can help clear tumor cells, chronic immune activation contributes to the therapy’s inflammatory side effects.
Furthermore, the “Abscopal Effect” is a rare but fascinating systemic phenomenon. This occurs when localized radiation to a primary tumor triggers an immune response that leads to the regression of distant, untreated metastases. This suggests that radiation can act as an in situ tumor vaccine, releasing neoantigens that prime T-cells to hunt down cancer throughout the body.
Systemic Risk Factors and Radiosensitivity
Radiation therapy creates special challenges for healing. Unlike surgical wounds, which follow a clear healing process, radiation can cause a long-lasting wound with low oxygen, fewer cells, and poor blood supply. This makes it hard for stem cells to repair the tissue. To help healing, doctors may use treatments like hyperbaric oxygen therapy or medicines that prevent scarring.
Send us all your questions or requests, and our expert team will assist you.
Radiation fatigue is different from fatigue caused by lack of sleep. It is caused by the body’s massive energy expenditure to repair damage to healthy cells and process the waste products from dying cancer cells. Additionally, the release of inflammatory chemicals (cytokines) during treatment contributes to a systemic feeling of exhaustion that can persist for weeks after treatment ends.
Radiation recall is a rare inflammatory skin reaction that occurs in a previously irradiated area after the administration of certain chemotherapy drugs (like doxorubicin or taxanes). It looks like a severe sunburn reappearing in the exact shape of the old radiation field, even months or years after the radiation was finished, triggered by the new drug.
Yes, there is a small, long-term risk that radiation can induce a “secondary malignancy.” This happens because the radiation can cause mutations in the DNA of healthy cells in the treatment field. These secondary cancers (often sarcomas or leukemias) typically appear 10 to 20 years after the initial treatment. Modern techniques aim to minimize this risk by reducing the dose to healthy tissue.
Radiation must pass through the skin to reach internal tumors. The basal cells of the skin divide rapidly to replace the surface layer. Radiation damages these stem cells, preventing them from replenishing the skin that naturally sheds. This leads to redness, peeling, and sometimes blistering, similar to a burn, which heals once the stem cells recover after treatment.
If the reproductive organs (testes or ovaries) are in or near the radiation field, fertility can be temporarily or permanently compromised. Even scattered radiation can damage sensitive germ cells. Fertility preservation options, such as sperm banking or egg freezing, and surgical transposition (moving the ovaries out of the beam’s path) are critical considerations before starting treatment.
Your Comparison List (you must select at least 2 packages)
